SCHEMBL55420

SCHEMBL55420

[O]C(=O)N1CCOCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL786679 0.79 SMN1; SMN2 (0.59)
SCHEMBL2899860 0.79 MEN1 (0.80)
SCHEMBL6040035 0.78 MEN1 (0.62)
SCHEMBL3954355 0.78 MEN1 (0.86)
SCHEMBL9541712 0.77
SCHEMBL11741744 0.77 MEN1 (0.85)
Hydrochloric Acid SCHEMBL27660773 0.77 MEN1 (0.76)
SCHEMBL27840293 0.77 CA12 (0.56)
Hydrochloric Acid SCHEMBL28000052 0.77 MEN1 (0.76)
SCHEMBL55421 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2316 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117986215-A 2-Phenyl-4-acyl benzofurans, preparation and application thereof 中国医学科学院药物研究所 2024-05-07 CN claimed
US-10919856-B2 Cyclohexene compounds and use thereof GUANGZHOU HENOVCOM BIOSCIENCE CO. LTD. (CN) 2021-02-16 US claimed
EP-2786990-B1 2-AMINATED METHYLENE OR 2-ESTERIFIED METHYLENE TANSHINONE DERIVATIVES, AND PREPARATION METHOD AND APPLICATION THEREOF HANGZHOU BENSHENG PHARMACEUTICAL CO LTD (CN) 2018-08-08 EP claimed
EP-2350068-B1 UREA DERIVATIVES OF SUBSTITUTED NORTROPANES, MEDICAMENTS CONTAINING SUCH COMPOUNDS AND THEIR USE BOEHRINGER INGELHEIM INT (DE) 2017-08-30 EP claimed
US-9328083-B2 2-aminated methylene or 2-esterified methylene tanshinone derivatives, and preparation method and application thereof HANGZHOU BENSHENG PHARMACEUTICAL CO., LTD. (CN) 2016-05-03 US claimed
EP-2318403-B1 Aryl- and heteroarylcarbonyl derivatives of substituted nortropanes, medicaments containing such compounds and their use BOEHRINGER INGELHEIM INT (DE) 2015-12-23 EP claimed
EP-2885279-A1 CYCLOPENTYLPYRAZOLES AS N-TYPE CALCIUM CHANNEL BLOCKERS Janssen Pharmaceutica, N.V. (BE) 2015-06-24 EP claimed
US-20150126552-A1 2-AMINATED METHYLENE OR 2-ESTERIFIED METHYLENE TANSHINONE DERIVATIVES, AND PREPARATION METHOD AND APPLICATION THEREOF HANGZHOU BENSHENG PHARMACEUTICAL CO., LTD. (CN) 2015-05-07 US claimed
US-8946438-B2 Benzamides, production thereof, and use thereof as medicaments BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-02-03 US claimed
EP-2786990-A1 2-AMINATED METHYLENE OR 2-ESTERIFIED METHYLENE TANSHINONE DERIVATIVES, AND PREPARATION METHOD AND APPLICATION THEREOF Hangzhou Bensheng Pharmaceutical Co., Ltd. (CN) 2014-10-08 EP claimed
US-5753652-A Antiretroviral hydrazine derivatives NOVARTIS CORPORATION (US) 1998-05-19 US claimed
EP-0604368-B1 Anti retroviral hydrazine derivatives CIBA GEIGY AG (CH) 1996-09-18 EP claimed
EP-0719552-A2 Pharmaceutical composition comprising a quinone derivative or a hydroquinone thereof for treating dermatitis Takeda Chemical Industries, Ltd. (JP) 1996-07-03 EP claimed
EP-0653427-A1 Galanthamine derivatives, a process for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1995-05-17 EP claimed
US-5405847-A Antiallergic, antiasthmatic, anxiolytic, hypotensive agents ASTA MEDICA AKTIENGESELLSCHAFT (DE) 1995-04-11 US claimed
EP-0229667-B1 Peptidylaminodiols ABBOTT LAB (US) 1994-07-13 EP claimed
EP-0604368-A1 Anti retroviral hydrazine derivatives CIBA-GEIGY AG (CH) 1994-06-29 EP claimed
EP-0584487-A2 4,5-Dihydro-4-oxopyrrolo (1,2-a) quinoxalines and aza-analoges and process for their preparation ASTA Medica Aktiengesellschaft (DE) 1994-03-02 EP claimed
US-4845079-A HYPOTENSIVE, RENIN INHIBITION ABBOTT LABORATORIES 1989-07-04 US claimed
EP-0229667-A2 Peptidylaminodiols ABBOTT LABORATORIES (US) 1987-07-22 EP claimed